Navigation Links
ThermoGenesis Presentation at Rodman & Renshaw Conference
Date:11/7/2008

RANCHO CORDOVA, Calif., Nov. 7 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today that it will be participating in the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008.

The Company's presentation by Dr. William Osgood, the Company's CEO, will begin at 2:50 p.m., Eastern Standard Time (11:50 am, Pacific Standard Time), and will be held at the New York Palace Hotel, located at 455 Madison Ave., New York, NY 10022.

Webcast

The presentation will be webcast LIVE and archived for 90 days, streaming video and PowerPoint slides. Access is available by logging on to the conference website http://www.wsw.com/webcast/rrshq14/kool or by going to the Company's website http://www.thermogenesis.com. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

ThermoGenesis Corp.

Web site: http://www.thermogenesis.com

Contact: Investor Relations

+1-916-858-5107, or

ir@thermogenesis.
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
7. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
8. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
9. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
10. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
11. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  For people with ... brighten their day. The biotechnology company, located in the ... one of the best potential therapies yet for people ... entitled, " Correction of Down syndrome and Edwards syndrome ... journal DNA Research . Elixirgen plans to develop ...
(Date:8/31/2015)... 2015  RXi Pharmaceuticals Corporation (NASDAQ: RXII ... developing innovative therapies primarily in the areas of ... review period following the filing of the Company,s ... the U.S. Food and Drug Administration (FDA) has ... Logo -  http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:8/31/2015)... HAYWARD, Calif. and SHANGHAI ... Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, ... Phase 2 clinical study for its lead drug ... designed to treat drug-resistant bacteria such as MRSA ... safer and better tolerated therapeutic option than currently ...
(Date:8/31/2015)... 2015 LabStyle Innovations Corp. (OTCQB: DRIO), ... announced it recently closed a round of funding ... to support the global rollout and initial U.S. ... diabetes management solution that includes novel software applications ... monitoring device, and for working capital purposes. The ...
Breaking Biology Technology:New Down syndrome therapy discovered 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4
... Something that was always taken for granted was the quality ... Sprint commercials, they emphasized that "you can hear a pin ... infrastructure. , ,The old Bell system also had very ... from analog to digital lines with digital repeaters (amplifiers) that ...
... multi-national corporations have decided to lease space in the ... and Eaton Corp. will have sales offices in ... management for Irgens Development Partners, LLC . , ... a global manufacturer of automotive systems, plans to open a ...
... Wis. - In what many in state government consider ... for the consolidation of computer servers in state government, but ... according to State CIO Matt Miszewski. , ,The revised timetable ... large agencies, the Department of Corrections and the ...
Cached Biology Technology:Is traditional voice quality an oxymoron with today's cellular, VoIP? 2Is traditional voice quality an oxymoron with today's cellular, VoIP? 3State alters schedule for server consolidation 2State alters schedule for server consolidation 3State alters schedule for server consolidation 4
(Date:8/11/2015)... August 11, 2015 Today, ZUK announced its ... as well as expected revenues in 2015 that relate to sales ... revenue guidance of approximately 2,200 MSEK for 2015. Jörgen ... prominent smartphone manufacturer in China ... selected FPC1 155 for Z1 ...
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... is available in Spanish . , Adolescents of ... and regular physical activity present increased levels of insulin and ... appetite control and energy expenditure. This was the conclusion drawn ... of the University of Granada . Further, after thorough ...
... of diabetes risk than does BMI. This is the ... the German Institute for Nutritional Research in Potsdam-Rehbrcke, in ... (Dtsch Arztebl Int 2010; 107[26]: 470-6). Current guidelines ... overweight should be based on the determination of the ...
... Minimally invasive surgery is increasingly common and effective for ... which use slender, handheld tools inserted into the body ... the most important factor determining the success of the ... Polytechnic Institute has won a $2.3 million federal grant ...
Cached Biology News:Children in good shape have better appetite control and energy expenditure 2Designing touch-sensitive virtual reality tools to train and test tomorrow's surgeons 2Designing touch-sensitive virtual reality tools to train and test tomorrow's surgeons 3